The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1035
September 11, 1998
View Complete Issue         Table of Contents 2019 
Two New Antiplatelet Drugs for Angioplasty and Acute Coronary Syndromes
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Two New Antiplatelet Drugs for Angioplasty and Acute Coronary Syndromes
September 11, 1998 (Issue: 1035)
Two new platelet glycoprotein IIb/IIIa receptor antagonists have been approved for marketing by the US Food and Drug Administration (FDA). Eptifibatide (ep ti fi' ba tyde; Integrilin - Cor, Key) is approved for use in acute coronary syndromes...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Two New Antiplatelet Drugs for Angioplasty and Acute Coronary Syndromes
Article code: 1035a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.